Axis Imaging

06/22/2026

Harrison.ai today launched Harrison.Rad 1.5, a radiology foundation model that can reason over images and clinical context, including priors, to produce a draft report for review by a radiologist.

Available now for research at chat.harrison.ai and API access on request, Harrison.Rad 1.5 was the only AI model to pass the FRCR 2B Short Case exam, the standard used to certify UK radiologists, while every other radiology-specific and frontier model evaluated fell short.

https://axisimagingnews.com/market-trends/cloud-computing/machine-learning-ai/harrison-ai-unveils-radiology-ai-model-designed-draft-reports-images-priors

Harrison.ai today launched Harrison.Rad 1.5, a radiology foundation model that can reason over images and clinical context.

06/18/2026

Medical imaging is evolving faster than ever.

From AI-powered diagnostics and imaging informatics to regulatory updates, workflow innovations, and emerging technologies, staying informed is critical for today's imaging professionals.

Subscribe to AXIS Imaging News and get the latest radiology and imaging news, expert insights, and technology trends delivered directly to your inbox.

📩 Sign up today: https://lnkd.in/ggE7FyGU

hashtag hashtag # AxisImagingNews hashtag hashtag

06/18/2026

Hologic Inc announced a legal victory in the Unified Patent Court in Germany, which ruled that Siemens infringed on a patent related to Hologic mammography technology. According to a company announcement, the court issued an injunction prohibiting Siemens from manufacturing, marketing, or selling its Mammomat B.brilliant systems in Germany, France, and the Netherlands.

The Unified Patent Court in Germany ruled that Siemens infringed on a patent related to Hologic mammography technology.

06/17/2026

Embolization of abnormal blood vessels using rapidly resorbable gelatin-based microspheres is safe and provides significant, lasting pain relief and functional improvement for patients with osteoarthritis-related knee pain, according to a study published in Radiology.

Embolization of abnormal blood vessels provides pain relief and functional improvement for patients with osteoarthritis knee pain.

06/16/2026

Varist announced the introduction of its DICOM Detection Engine, designed to safeguard healthcare communications networks, EHR, and PACS from malware.

“A picture is worth a thousand words, especially when lives depend on it, and threat actors may be looking to use that to their advantage,” says chief technology officer Siggi Petursson. “Varist’s specialized detection for healthcare environments finds new self-evolving threats designed to evade detection by conventional systems, without adding delays or compromising patients’ care and privacy.”

Varist's DICOM Detection Engine is designed to safeguard healthcare communications networks, EHR, and PACS.

06/15/2026

Bayer has received FDA approval for Ambelvist (gadoquatrane), a new contrast agent for MRI. The agent is indicated for use in adult and pediatric patients, including term neonates, to detect and visualize lesions with abnormal vascularity in the central nervous system and other body regions.

Bayer has received US Food and Drug Administration approval for Ambelvist (gadoquatrane), a new contrast agent for MRI.

06/13/2026

Sirona Medical and Everlight Radiology have entered a five-year partnership to deploy Sirona’s RadOS platform across Everlight’s global operations. Everlight, a multinational teleradiology provider, will replace its current PACS and reporting solutions with the unified, cloud-native platform in Australia, New Zealand, Ireland, the United Kingdom, the United Arab Emirates, and South Africa.

The deployment will support 800 radiologists providing care to 350 hospitals.

Sirona Medical and Everlight Radiology entered a five-year partnership to deploy Sirona’s RadOS platform across Everlight’s global operations.

06/12/2026

A study published in Radiology found that long-term exposure to moderate levels of air pollution was associated with more advanced coronary artery disease, based on cardiac CT findings from more than 11,000 adults.

“This is one of the largest studies to use cardiac CT to show that air pollution is linked to more advanced coronary artery disease—going beyond calcium scoring to include total plaque burden and obstructive disease—in a population with moderate exposure levels typical of high-income countries,” says senior author Kate Hanneman, MD, MPH, vice chair and associate professor at the University of Toronto.

A study found that exposure to air pollution was associated with more advanced coronary artery disease, based on cardiac CT findings.

06/12/2026

Cortechs.ai, specializing in AI-powered neuroimaging and quantitative analysis solutions, announced a collaboration with Microsoft to integrate advanced imaging biomarkers and AI-driven insights into clinical radiology workflows. This collaboration aims to enhance diagnostic precision, streamline reporting, and accelerate clinical decision-making at scale.

“Radiology is at a critical inflection point,” says Jared Dixon, VP of global sales of Cortechs.ai. “By collaborating with Microsoft, we’re embedding clinically validated AI directly into the environments radiologists use every day by removing friction and enabling smarter, faster decisions that ultimately benefit patients.”

https://axisimagingnews.com/radiology-products/radiology-software/cortechs-ai-and-microsoft-partner-to-bring-ai-imaging-insights-into-radiology-workflows

Cortechs.ai is ollaborating with Microsoft to integrate advanced imaging biomarkers and AI-driven insights into clinical radiology workflows.

06/11/2026

Subtle Medical announced US Food and Drug Administration (FDA) clearance of SubtleHD(PET), an AI-based PET image enhancement software designed for use with PET/CT and PET/MR systems.

According to the company, the software supports all FDA-approved PET radiotracers and is intended to improve image quality from accelerated low-count PET acquisitions. Subtle Medical says the software can support PET imaging workflows with scan times reduced by up to 75% on existing scanners.

Subtle Medical announced FDA clearance of SubtleHD(PET), an AI-based PET image enhancement software for use with PET/CT and PET/MR systems.